As GLP-1 generics flood market, govt intensifies surveillance NEW DELHI: With prices of GLP-1 drugs crashing and their generic versions flooding the market, govt has cracked down on their misuse, inspecting 49 businesses and issuing notices while also flagging risks of unsupervised consumption in a detailed advisory.To ensure ethical pharmaceutical practices, Drug Controller General of India has intensified surveillance of unauthorised sale and promotion of the drugs. In India, GLP-1 medicines can be prescribed only by endocrinologists, internal medicine specialists and cardiologists.Officials have raised concerns over their growing on-demand availability through retail pharmacies, online platforms, wholesalers and wellness clinics. Inspections across the country found violations such as improper prescriptions and misleading marketing. An advisory has directed manufacturers to stop advertisements promoting non-prescription use, warning of licence cancellation, fines and legal action.GLP-1 drugs, used to treat type 2 diabetes and obesity, carry risks if misused. Side effects range from vomiting to pancreatitis, kidney injury and bowel obstruction.End of ArticleFollow Us On Social MediaVideosFrom Stealth Warships To Silent Submarines: These Naval Deployments Paralyzed Pak In Op SindoorAmid Hormuz Crisis, India May Get First Delivery Of Iranian Crude Oil After 7 YearsIndia Eyes Coal Gasification As Substitute For Energy Imports Amid Iran War Supply ShocksKerala Election 2026: LDF vs UDF vs BJP, Who Will Win the Battle?| PINARAYI VIJAYANTrump Says Iran War Could End In 2-3 Weeks, With Or Without Deal; US Planning To Pull Out Of NATO?Jaishankar’s ‘Europe’s Problem’ Remark Comes Full Circle As UK Adopts ‘Not Our War’ Stance On IranPM Modi To Chair Key Security Meet To Review West Asia Situation Amid Energy, Supply Chain ConcernsRBI Resets Digital Payments Rule In India To Fight Rising Fraud Risks, OTP Alone Won’t Work AnymoreINS Malwan Delivered To Indian Navy, Strengthens India’s Coastal Anti-Submarine Warfare’Where Was Your PM?’ Mallikarjun Kharge Attacks Modi Govt, Sparks War Of Words With Kiren Rijiju123PhotostoriesLow energy, poor sleep, weight gain? Doctors explain early metabolic decline, and how to fix itHanuman Jayanti 2026: 10 most powerful Hanuman temples in India7 ways meditation scientifically rewires the brain8 easy-care succulents that reward you with stunning flowers10 home names inspired by Indian traditions and their meaningsHanuman Jayanti 2026: Why Laddoos are offered as bhog to Lord Hanuman and other traditional dishes prepared during the festival5 powerful benefits of chanting Om Namah Shivaya10 everyday items linked to cancer risk we use daily: Doctor explains hidden dangers and simple ways to reduce exposure10 ‘superpowers’ women possess that are biologically impossible for men13 Full moons of 2026: Here are their dates and names123Hot PicksUAE healthcare rulesLeBron JamesNASA Artemis IIKristi Noem HusbandUS Iran WarPublic holidays April 2026Bank Holidays AprilTop TrendingJa MorantNASA Artemis IINew Income Tax Act 2025Insolvency and Bankruptcy CodeUS birthright citizenshipPunjab BJP blastIran ceasefireArjun TendulkarSameer RizviIran war news
NEW DELHI: With prices of GLP-1 drugs crashing and their generic versions flooding the market, govt has cracked down on their misuse, inspecting 49 businesses and issuing notices while also flagging risks of unsupervised consumption in a detailed advisory.To ensure ethical pharmaceutical practices, Drug Controller General of India has intensified surveillance of unauthorised sale and promotion of the drugs. In India, GLP-1 medicines can be prescribed only by endocrinologists, internal medicine specialists and cardiologists.Officials have raised concerns over their growing on-demand availability through retail pharmacies, online platforms, wholesalers and wellness clinics. Inspections across the country found violations such as improper prescriptions and misleading marketing. An advisory has directed manufacturers to stop advertisements promoting non-prescription use, warning of licence cancellation, fines and legal action.GLP-1 drugs, used to treat type 2 diabetes and obesity, carry risks if misused. Side effects range from vomiting to pancreatitis, kidney injury and bowel obstruction.